Probiotics Market Research Report - Forecast till 2027

Probiotics Market: Information by Type (Bifidobacterium, Lactobacillus and others), Application (Functional Food & Beverages, Dietary Supplements, Animal Nutrition and others) and Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa) - Forecast till 2027

ID: MRFR/F-B & N/0460-CR | February 2021 | Region: Global | 111 pages

Probiotics Market Synopsis



Probiotics Market is expected to register a CAGR of
8.48% to reach USD 3,257.0 Million by 2025. Probiotics are live microbials that are used to maintain and restore gut microflora. These probiotics have found its application in various processed foods and preventive healthcare products for humans as well as animals or livestock. The major types of probiotic bacteria species used in application industries include those of the Bifidobacterium and Lactobacillus genus.


The use of probiotics has gained popularity in recent years with increasing demand in various industries. An emphasis on improving digestive health in humans and animals along with surging demand for natural functional ingredients in application industries are the major driving factors for the Probiotics industry growth. Rising consumer awareness about the benefits of probiotics and preventive healthcare has boosted the demand for probiotics, thereby propelling market growth.

Market Dynamics


Probiotics Market is expected to register significant growth during the forecast period. Hectic daily schedules, long working hours, and sedentary lifestyles have impacted eating habits as well as food choices, resulting in an increased prevalence of various lifestyle-related conditions such as diabetes and obesity. This has led to increased demand for probiotic food & beverages. Moreover, surging demand for probiotics in developed and developing countries is propelling manufacturers of probiotics and probiotic products to focus on innovation. Thus, product innovation and research and development have led to new growth opportunities for probiotic manufacturers.  


Global Probiotics Market Revenue, by Application, 2025 (USD Million)  Probiotics Market


Sources: MRFR Analysis


Segmentation


The functional food & beverages segment is expected to be largest, registering a substantial CAGR to reach USD 1,749.6 million by the end of 2025. High consumption of beverages, especially functional beverages, and dairy-based products is the primary determinant driving the growth of the segment. However, the dietary supplements segment is projected to be the fastest-growing during the forecast period.  


Global Probiotics Market Share, by Region, 2018 (%)      Probiotics Market  


Sources: MRFR Analysis


Regional Analysis


The North American probiotics market is expected to be the largest during the forecast period. The regional market accounted for 31.60% of the total market share in 2018. The US was the major contributor to the growth of the market. Inclination toward the consumption of healthy and functional food & beverages is rising in the country, leading to an increased application of probiotics in the food industry. The Asia-Pacific market also holds a prominent share of the global probiotics industry and is projected to exhibit the highest CAGR during the forecast period. Growth of the application industries in the region is driving the growth of the probiotics industry. In Europe, Germany, France, and the UK are the key countries that are contributing significantly to market growth.


Key Players


The prominent players in the Market are CHR-Hansen A/S (Denmark), Novozymes A/S (Denmark), Lallemand Inc. (Canada), Probi AB (Sweden), Kerry Group (Ireland), Sabinsa Corporation (US), DowDupont Inc. (US), Synbio Tech Inc. (Taiwan), Roelmi HPC (Italy), UAS Laboratories LLC (US), Probiotical SpA (Italy), Greentech SA (France), Biosearch, SA (Spain), and BioCC OÜ (Estonia) .


The players operating in the global probiotics industry are focusing on product launches, mergers & acquisitions, joint ventures, and strengthening their global footprints by entering untapped markets.   


Market Segmentation


Global Probiotics Market, by Type



  • Bifidobacterium

  • Lactobacillus

  • Others


Global Probiotics Market, by Application



  • Functional Food & Beverages

  • Dietary Supplements

  • Animal Nutrition

  • Others


Global Probiotics Market, by Region



  • North America

    • US

    • Canada

    • Mexico





  • Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Russia

    • Rest of Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • Vietnam

    • South Korea

    • Rest of Asia-Pacific





  • South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Rest of South America





  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • Egypt

    • Nigeria

    • South Africa

    • Rest of the Middle East & Africa




Available Additional Customizations



  • Company Profiles of Regional Key Players

  • Country-Level Analysis


Intended Audience



  • Probiotics manufacturers

  • Baby food manufacturers

  • Beverage industry

  • Dairy industry

  • Food processors

  • Animal feed manufacturers

  • Dietary supplements manufacturers

  • Traders, wholesalers, and distributors

  • Governments, associations, and industrial bodies

  • Investors and trade experts



Frequently Asked Questions (FAQ) :


Probiotics Market is projected to have a CAGR of 8.48% during the forecast period.

Probiotics Market has a valuation of USD 3,257 million by 2025.

The projected valuation would of the functional food & beverages segment of Probiotics Market would be USD 1749.6 million.

The North American Probiotics Market share in 2018 was 31.6%.

The US would lead the North American Probiotics Market.

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS 19

1.1.1 GLOBAL PROBIOTICS MARKET, BY TYPE 20

1.1.2 GLOBAL PREBIOTICS MARKET, BY APPLICATION 21

1.1.3 GLOBAL PROBIOTICS MARKET, BY REGION 22

2 MARKET INTRODUCTION

2.1 DEFINITION 23

2.2 SCOPE OF THE STUDY 23

2.3 RESEARCH OBJECTIVE 23

2.4 MARKET STRUCTURE 24

2.5 KEY BUYING CRITERIA 24

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 25

3.2 PRIMARY RESEARCH 26

3.3 SECONDARY RESEARCH 27

3.4 MARKET SIZE ESTIMATION 27

3.5 FORECAST MODEL 29

3.6 LIST OF ASSUMPTIONS 30

4 MARKET INSIGHTS

5 MARKET DYNAMICS

5.1 INTRODUCTION 34

5.2 DRIVERS 35

5.2.1 INCREASING EMPHASIS ON IMPROVING DIGESTIVE HEALTH IN HUMANS AND ANIMALS 35

5.2.2 SURGING DEMAND FOR NATURAL FUNCTIONAL INGREDIENTS IN APPLICATION INDUSTRIES 35

5.2.3 DRIVERS IMPACT ANALYSIS 36

5.3 RESTRAINT 36

5.3.1 REGULATORY CONSTRAINTS 36

5.3.2 RESTRAINTS IMPACT ANALYSIS 37

5.4 OPPORTUNITIES 37

5.4.1 PRODUCT INNOVATION 37

6 MARKET FACTOR ANALYSIS

6.1 VALUE CHAIN ANALYSIS 38

6.1.1 RAW MATERIAL PROCUREMENT 40

6.1.2 PROCESSING 40

6.1.3 PACKAGING 40

6.2 SUPPLY CHAIN ANALYSIS 41

6.3 PORTER’S FIVE FORCES MODEL 42

6.3.1 THREAT OF NEW ENTRANTS 43

6.3.2 BARGAINING POWER OF SUPPLIERS 43

6.3.3 BARGAINING POWER OF BUYERS 43

6.3.4 THREAT OF SUBSTITUTES 43

6.3.5 INTENSITY OF RIVALRY 43

7 PROBIOTICS MARKET, BY TYPE

7.1 OVERVIEW 44

7.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY TYPE, 2020–2027 45

7.2 BIFIDOBACTERIUM 46

7.2.1 BIFIDOBACTERIUM: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 46

7.3 LACTOBACILLUS 47

7.3.1 LACTOBACILLUS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 47

7.4 OTHERS 48

7.4.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 48

8 PROBIOTICS MARKET, BY APPLICATION

8.1 OVERVIEW 49

8.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2020–2027 50

8.2 FUNCTIONAL FOOD & BEVERAGES 51

8.2.1 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 51

8.3 DIETARY SUPPLEMENTS 52

8.3.1 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 52

8.4 ANIMAL NUTRITION 53

8.4.1 ANIMAL NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 53

8.5 OTHERS 54

8.5.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 54

9 GLOBAL PROBIOTICS MARKET, BY REGION

9.1 OVERVIEW 55

9.2 NORTH AMERICA 57

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.2.1 US 60

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.2.2 CANADA 61

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.2.3 MEXICO 62

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3 EUROPE 64

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.1 GERMANY 66

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.2 UK 68

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.3 FRANCE 69

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.4 SPAIN 71

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.5 ITALY 72

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.6 RUSSIA 73

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.3.7 REST OF EUROPE 75

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4 ASIA-PACIFIC 77

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.1 CHINA 80

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.2 JAPAN 81

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.3 INDIA 82

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.4 AUSTRALIA 84

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.5 VIETNAM 85

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.6 SOUTH KOREA 86

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.4.7 REST OF ASIA-PACIFIC 88

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5 SOUTH AMERICA 90

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5.1 BRAZIL 92

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5.2 ARGENTINA 94

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5.3 COLOMBIA 95

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5.4 CHILE 96

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.5.5 REST OF SOUTH AMERICA 98

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6 MIDDLE EAST & AFRICA 100

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.1 SAUDI ARABIA 102

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.2 UAE 104

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.3 EGYPT 105

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.4 NIGERIA 106

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.5 SOUTH AFRICA 108

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

9.6.6 REST OF MIDDLE EAST & AFRICA 109

PROBIOTICS MARKET, BY TYPE

PROBIOTICS MARKET, BY APPLICATION

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION 111

10.2 COMPETITIVE BENCHMARKING 112

10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 113

10.3.1 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS 113

10.3.2 MERGERS & ACQUISITIONS 113

10.3.3 JOINT VENTURES 113

10.3.4 EXPANSION 114

11 COMPANY PROFILES

11.1 CHR. HANSEN A/S 115

11.1.1 COMPANY OVERVIEW 115

11.1.2 FINANCIAL OVERVIEW 115

11.1.3 PRODUCTS OFFERED 116

11.1.4 KEY DEVELOPMENTS 116

11.1.5 SWOT ANALYSIS 117

11.1.6 KEY STRATEGIES 117

11.2 NOVOZYMES A/S 118

11.2.1 COMPANY OVERVIEW 118

11.2.2 FINANCIAL OVERVIEW 118

11.2.3 PRODUCTS OFFERED 119

11.2.4 KEY DEVELOPMENTS 119

11.2.5 SWOT ANALYSIS 120

11.2.6 KEY STRATEGIES 120

11.3 LALLEMAND INC. 121

11.3.1 COMPANY OVERVIEW 121

11.3.2 FINANCIAL OVERVIEW 121

11.3.3 PRODUCTS OFFERED 121

11.3.4 KEY DEVELOPMENTS 121

11.3.5 SWOT ANALYSIS 122

11.3.6 KEY STRATEGIES 122

11.4 PROBI AB 123

11.4.1 COMPANY OVERVIEW 123

11.4.2 FINANCIAL OVERVIEW 123

11.4.3 PRODUCTS OFFERED 124

11.4.4 KEY DEVELOPMENTS 124

11.4.5 SWOT ANALYSIS 125

11.4.6 KEY STRATEGIES 125

11.5 KERRY GROUP PLC 126

11.5.1 COMPANY OVERVIEW 126

11.5.2 FINANCIAL OVERVIEW 126

11.5.3 PRODUCTS OFFERED 127

11.5.4 KEY DEVELOPMENTS 127

11.5.5 SWOT ANALYSIS 127

11.5.6 KEY STRATEGIES 128

11.6 SABINSA CORPORATION 129

11.6.1 COMPANY OVERVIEW 129

11.6.2 FINANCIAL OVERVIEW 129

11.6.3 PRODUCTS OFFERED 129

11.6.4 KEY DEVELOPMENTS 129

11.6.5 SWOT ANALYSIS 130

11.6.6 KEY STRATEGIES 130

11.7 DOWDUPONT INC. 131

11.7.1 COMPANY OVERVIEW 131

11.7.2 FINANCIAL OVERVIEW 131

11.7.3 PRODUCTS OFFERED 132

11.7.4 KEY DEVELOPMENTS 132

11.7.5 SWOT ANALYSIS 133

11.7.6 KEY STRATEGIES 133

11.8 SYNBIO TECH INC. 134

11.8.1 COMPANY OVERVIEW 134

11.8.2 FINANCIAL OVERVIEW 134

11.8.3 PRODUCTS OFFERED 134

11.8.4 KEY DEVELOPMENTS 135

11.8.5 SWOT ANALYSIS 136

11.8.6 KEY STRATEGIES 136

11.9 ROELMI HPC 137

11.9.1 COMPANY OVERVIEW 137

11.9.2 FINANCIAL OVERVIEW 137

11.9.3 PRODUCTS OFFERED 137

11.9.4 KEY DEVELOPMENT 138

11.9.5 SWOT ANALYSIS 138

11.9.6 KEY STRATEGIES 138

11.10 UAS LABORATORIES LLC 139

11.10.1 COMPANY OVERVIEW 139

11.10.2 FINANCIAL OVERVIEW 139

11.10.3 PRODUCTS OFFERED 139

11.10.4 KEY DEVELOPMENTS 140

11.10.5 SWOT ANALYSIS 140

11.10.6 KEY STRATEGIES 141

11.11 PROBIOTICAL SPA 142

11.11.1 COMPANY OVERVIEW 142

11.11.2 FINANCIAL OVERVIEW 142

11.11.3 PRODUCTS OFFERED 142

11.11.4 KEY DEVELOPMENTS 142

11.11.5 SWOT ANALYSIS 143

11.11.6 KEY STRATEGIES 143

11.12 GREENTECH SA 144

11.12.1 COMPANY OVERVIEW 144

11.12.2 FINANCIAL OVERVIEW 144

11.12.3 PRODUCTS OFFERED 144

11.12.4 KEY DEVELOPMENTS 144

11.12.5 SWOT ANALYSIS 145

11.12.6 KEY STRATEGIES 145

11.13 BIOSEARCH, SA 146

11.13.1 COMPANY OVERVIEW 146

11.13.2 FINANCIAL OVERVIEW 146

11.13.3 PRODUCTS OFFERED 147

11.13.4 KEY DEVELOPMENTS 147

11.13.5 SWOT ANALYSIS 147

11.13.6 KEY STRATEGIES 148

11.14 BIOCC OÜ 149

11.14.1 COMPANY OVERVIEW 149

11.14.2 FINANCIAL OVERVIEW 149

11.14.3 PRODUCTS OFFERED 150

11.14.4 KEY DEVELOPMENTS 150

11.14.5 BIOCC OÜ PATENTS: PROBITOTICS MARKET 151

11.14.6 SWOT ANALYSIS 154

11.14.7 KEY STRATEGIES 155

12 APPENDIX

12.1 REFERENCES 156

13 List Of Tables

TABLE 1 PRIMARY INTERVIEWS 26

TABLE 2 LIST OF ASSUMPTIONS 30

TABLE 3 GLOBAL PROBIOTICS MARKET ESTIMATES, BY TYPE, 2020-2027 (USD MILLION) 45

TABLE 4 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 5 BIFIDOBACTERIUM: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 6 BIFIDOBACTERIUM: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 7 LACTOBACILLUS: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 47

TABLE 8 LACTOBACILLUS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 9 OTHERS: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 10 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 11 GLOBAL PROBIOTICS MARKET ESTIMATES, BY APPLICATION, 2020-2027 (USD MILLION) 50

TABLE 12 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2020–2027 (USD MILLION) 50

TABLE 13 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 51

TABLE 14 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 15 DIETARY SUPPLEMENTS: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 52

TABLE 16 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 52

TABLE 17 ANIMAL NUTRITION: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 53

TABLE 18 ANIMAL NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 19 OTHERS: MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 20 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 21 GLOBAL: PROBIOTICS MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 22 GLOBAL PROBIOTICS MARKET ESTIMATES, BY REGION, 2020-2027 (USD MILLION) 56

TABLE 23 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 24 NORTH AMERICA: MARKET ESTIMATES, BY COUNTRY, 2020-2027 (USD MILLION) 57

TABLE 25 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020–2027 (USD MILLION) 58

TABLE 26 NORTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 58

TABLE 27 NORTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 28 NORTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 59

TABLE 29 NORTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 30 US: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 31 US: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 32 US: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 60

TABLE 33 US: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 34 CANADA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 61

TABLE 35 CANADA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 36 CANADA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 62

TABLE 37 CANADA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 38 MEXICO: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 39 MEXICO: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 40 MEXICO: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 63

TABLE 41 MEXICO: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 42 EUROPE: MARKET ESTIMATES, BY COUNTRY, 2020-2027 (USD MILLION) 64

TABLE 43 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020–2027 (USD MILLION) 65

TABLE 44 EUROPE: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 45 EUROPE: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 46 EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 66

TABLE 47 EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 48 GERMANY: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 49 GERMANY: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 50 GERMANY: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 67

TABLE 51 GERMANY: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 52 UK: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 53 UK: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 54 UK: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68

TABLE 55 UK: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69

TABLE 56 FRANCE: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 69

TABLE 57 FRANCE: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 58 FRANCE: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70

TABLE 59 FRANCE: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 60 SPAIN: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 61 SPAIN: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 62 SPAIN: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 71

TABLE 63 SPAIN: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 64 ITALY: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 65 ITALY: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 66 ITALY: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 73

TABLE 67 ITALY: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 68 RUSSIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 69 RUSSIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 70 RUSSIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74

TABLE 71 RUSSIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 72 REST OF EUROPE: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 73 REST OF EUROPE: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 74 REST OF EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 75

TABLE 75 REST OF EUROPE: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 76 ASIA-PACIFIC: MARKET ESTIMATES, BY COUNTRY, 2020-2027 (USD MILLION) 77

TABLE 77 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020–2027 (USD MILLION) 78

TABLE 78 ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 79 ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 80 ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 79

TABLE 81 ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 82 CHINA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 83 CHINA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 84 CHINA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80

TABLE 85 CHINA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 86 JAPAN: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 81

TABLE 87 JAPAN: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 88 JAPAN: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 82

TABLE 89 JAPAN: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82

TABLE 90 INDIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 91 INDIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 92 INDIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 83

TABLE 93 INDIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 94 AUSTRALIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 95 AUSTRALIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 96 AUSTRALIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84

TABLE 97 AUSTRALIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85

TABLE 98 VIETNAM: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 99 VIETNAM: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 100 VIETNAM: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86

TABLE 101 VIETNAM: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 102 SOUTH KOREA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 103 SOUTH KOREA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 104 SOUTH KOREA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87

TABLE 105 SOUTH KOREA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 106 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 107 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 108 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88

TABLE 109 REST OF ASIA-PACIFIC: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 110 SOUTH AMERICA: MARKET ESTIMATES, BY COUNTRY, 2020-2027 (USD MILLION) 90

TABLE 111 SOUTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020–2027 (USD MILLION) 91

TABLE 112 SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 91

TABLE 113 SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 114 SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92

TABLE 115 SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92

TABLE 116 BRAZIL: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 117 BRAZIL: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 118 BRAZIL: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 93

TABLE 119 BRAZIL: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 120 ARGENTINA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 94

TABLE 121 ARGENTINA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 122 ARGENTINA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94

TABLE 123 ARGENTINA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 124 COLOMBIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 125 COLOMBIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 126 COLOMBIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 96

TABLE 127 COLOMBIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 128 CHILE: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 96

TABLE 129 CHILE: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 130 CHILE: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 97

TABLE 131 CHILE: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97

TABLE 132 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 98

TABLE 133 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 134 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98

TABLE 135 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99

TABLE 136 MIDDLE EAST & AFRICA: MARKET ESTIMATES, BY COUNTRY, 2020-2027 (USD MILLION) 100

TABLE 137 MIDDLE EAST & AFRICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2020–2027 (USD MILLION) 101

TABLE 138 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 101

TABLE 139 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 140 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 102

TABLE 141 MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 142 SAUDI ARABIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 102

TABLE 143 SAUDI ARABIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 144 SAUDI ARABIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 103

TABLE 145 SAUDI ARABIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103

TABLE 146 UAE: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 104

TABLE 147 UAE: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 148 UAE: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 104

TABLE 149 UAE: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 150 EGYPT: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 105

TABLE 151 EGYPT: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 152 EGYPT: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 106

TABLE 153 EGYPT: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106

TABLE 154 NIGERIA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 106

TABLE 155 NIGERIA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 156 NIGERIA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 107

TABLE 157 NIGERIA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107

TABLE 158 SOUTH AFRICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 108

TABLE 159 SOUTH AFRICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 160 SOUTH AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 108

TABLE 161 SOUTH AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109

TABLE 162 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2020-2027 (USD MILLION) 109

TABLE 163 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 164 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 110

TABLE 165 REST OF MIDDLE EAST & AFRICA: PROBIOTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110

TABLE 166 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS 113

TABLE 167 MERGERS & ACQUISITIONS 113

TABLE 168 JOINT VENTURES 113

TABLE 169 EXPANSION 114

TABLE 170 CHR. HANSEN A/S: PRODUCTS OFFERED 116

TABLE 171 CHR. HANSEN A/S: KEY DEVELOPMENTS 116

TABLE 172 NOVOZYMES A/S: PRODUCTS OFFERED 119

TABLE 173 NOVOZYMES A/S: KEY DEVELOPMENTS 119

TABLE 174 LALLEMAND INC.: PRODUCTS OFFERED 121

TABLE 175 PROBI AB: PRODUCTS OFFERED 124

TABLE 176 PROBI AB: KEY DEVELOPMENTS 124

TABLE 177 KERRY GROUP PLC: PRODUCTS OFFERED 127

TABLE 178 KERRY GROUP PLC: KEY DEVELOPMENTS 127

TABLE 179 SABINSA CORPORATION: PRODUCTS OFFERED 129

TABLE 180 DOWDUPONT INC.: PRODUCTS OFFERED 132

TABLE 181 DOWDUPONT INC.: KEY DEVELOPMENTS 132

TABLE 182 SYNBIO TECH INC.: PRODUCTS OFFERED 134

TABLE 183 SYNBIO TECH INC.: KEY DEVELOPMENTS 135

TABLE 184 ROELMI HPC: PRODUCTS OFFERED 137

TABLE 185 UAS LABORATORIES LLC: PRODUCTS OFFERED 139

TABLE 186 UAS LABORATORIES LLC: KEY DEVELOPMENTS 140

TABLE 187 PROBIOTICAL SPA: PRODUCTS OFFERED 142

TABLE 188 THE COMPANY OFFERS PROBIOTIC PRODUCTS FOR NUTRACEUTICAL AND FUNCTIONAL FOOD APPLICATIONS. THE DETAILED INFORMATION IS NOT AVAILABLE ON THE COMPANY WEBSITE. 144

TABLE 189 BIOSEARCH, SA: PRODUCTS OFFERED 147

TABLE 190 BIOCC OÜ: PRODUCTS OFFERED 150


14 List Of Figures

FIGURE 1 MARKET SYNOPSIS 18

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL PROBIOTICS MARKET, 2020 19

FIGURE 3 GLOBAL PROBIOTICS MARKET ANALYSIS, BY TYPE 20

FIGURE 4 GLOBAL PREBIOTICS MARKET ANALYSIS, BY APPLICATION 21

FIGURE 5 GLOBAL PROBIOTICS MARKET ANALYSIS, BY REGION, 2020 22

FIGURE 6 GLOBAL PROBIOTICS MARKET: STRUCTURE 24

FIGURE 7 KEY BUYING CRITERIA FOR PREBIOTICS 24

FIGURE 8 RESEARCH PROCESS 25

FIGURE 9 TOP-DOWN & BOTTOM-UP APPROACHES 28

FIGURE 10 NORTH AMERICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2020 VS 2027) 31

FIGURE 11 EUROPE: PROBIOTICS MARKET SIZE, BY COUNTRY (2020 VS 2027) 31

FIGURE 12 ASIA-PACIFIC: PROBIOTICS MARKET SIZE, BY COUNTRY (2020 VS 2027) 32

FIGURE 13 SOUTH AMERICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2020 VS 2027) 32

FIGURE 14 MIDDLE EAST & AFRICA: PROBIOTICS MARKET SIZE, BY COUNTRY (2020 VS 2027) 33

FIGURE 15 MARKET DYNAMICS OVERVIEW 34

FIGURE 16 DRIVERS IMPACT ANALYSIS: GLOBAL PROBIOTICS MARKET 36

FIGURE 17 RESTRAINTS IMPACT ANALYSIS: GLOBAL PROBIOTICS MARKET 37

FIGURE 18 VALUE CHAIN: GLOBAL PROBIOTICS MARKET 39

FIGURE 19 GLOBAL PROBIOTICS MARKET: SUPPLY CHAIN ANALYSIS 41

FIGURE 21 GLOBAL PROBIOTICS MARKET, BY TYPE, 2020 (% SHARE) 44

FIGURE 22 GLOBAL PROBIOTICS MARKET, BY TYPE, 2017–2027 (USD MILLION) 44

FIGURE 23 GLOBAL PROBIOTICS MARKET SHARE, BY APPLICATION, 2020 (% SHARE) 49

FIGURE 24 GLOBAL PROBIOTICS MARKET SIZE, BY APPLICATION, 2017–2027 (USD MILLION) 49

FIGURE 25 GLOBAL PROBIOTICS MARKET, BY REGION, 2017–2027 (USD MILLION) 55

FIGURE 26 GLOBAL PROBIOTICS MARKET, BY REGION, 2020 (% SHARE) 56

FIGURE 27 NORTH AMERICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 57

FIGURE 28 EUROPE: PROBIOTICS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 64

FIGURE 29 ASIA-PACIFIC: PROBIOTICS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 77

FIGURE 30 SOUTH AMERICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 90

FIGURE 31 MIDDLE EAST & AFRICA: PROBIOTICS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 100

FIGURE 32 CHR. HANSEN A/S: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 33 CHR. HANSEN A/S: SWOT ANALYSIS 117

FIGURE 34 NOVOZYMES A/S: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 35 NOVOZYMES A/S: SWOT ANALYSIS 120

FIGURE 36 LALLEMAND INC.: SWOT ANALYSIS 122

FIGURE 37 PROBI AB: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 38 PROBI AB: SWOT ANALYSIS 125

FIGURE 39 KERRY GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 40 KERRY GROUP PLC: SWOT ANALYSIS 127

FIGURE 41 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 129

FIGURE 42 SABINSA CORPORATION: SWOT ANALYSIS 130

FIGURE 43 DOWDUPONT INC.: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 44 DOWDUPONT INC.: SWOT ANALYSIS 133

FIGURE 45 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 134

FIGURE 46 SYNBIO TECH INC.: SWOT ANALYSIS 136

FIGURE 47 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 137

FIGURE 48 THERE HAVE BEEN NO RECENT DEVELOPMENTS BY THE COMPANY IN THE GLOBAL PROBIOTICS MARKET. 138

FIGURE 49 ROELMI HPC: SWOT ANALYSIS 138

FIGURE 50 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 139

FIGURE 51 UAS LABORATORIES LLC: SWOT ANALYSIS 140

FIGURE 52 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 142

FIGURE 53 PROBIOTICAL SPA: SWOT ANALYSIS 143

FIGURE 54 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE ON PUBLIC DOMAIN. 144

FIGURE 55 GREENTECH SA: SWOT ANALYSIS 145

FIGURE 56 BIOSEARCH SA: FINANCIAL OVERVIEW SNAPSHOT 146

FIGURE 57 BIOSEARCH, SA: SWOT ANALYSIS 147

FIGURE 58 BIOCC OÜ COMPANY: SWOT ANALYSIS 154